TXNDC5 and neoplasm: Nissom et al (18) demonstrated that poorly-differentiated hepatocellular carcinoma (HCC) exhibits upregulated TXNDC5 expression, but that the level is unchanged in well-differentiated HCC, and thus, it was hypothesized that the gene is involved in tumor progression.